Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone versus dexmedetomidine as adjuvants to bupivacaine for supraclavicular brachial plexus block
IRCT20141009019470N84Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone, dexmedetomidine and bupivacaine in Forearm Fracture (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Duration of sensory block, Onset of the sensory block and 2 more. Started Sep 2019; status: completed.
02
Drugs
dexamethasonedexmedetomidinebupivacaine
03
Conditions
Forearm Fracture
Beyond the preview
Go deeper on IRCT20141009019470N84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N84.